We are live on ! Find out more
DIA

Dean Investment Associates Portfolio holdings

AUM $710M
1-Year Est. Return 22.02%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+22.02%
3 Year Est. Return
+46.93%
5 Year Est. Return
+63.67%
10 Year Est. Return
+163.57%
AUM
$568M
AUM Growth
+$37.2M
Cap. Flow
-$4.41M
Cap. Flow %
-0.78%
Top 10 Hldgs %
12.5%
Holding
244
New
12
Increased
60
Reduced
153
Closed
13

Top Buys

Rank Stock Value
1
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$6.74M
2
SWX icon
Southwest Gas
SWX
+$2.75M
3
INTC icon
Intel
INTC
+$2.24M
4
HUM icon
Humana
HUM
+$2.02M
5
JOUT icon
Johnson Outdoors
JOUT
+$1.65M

Sector Composition

Rank Sector Weight
1 Financials 20.48%
2 Industrials 10.75%
3 Healthcare 10.47%
4 Consumer Staples 10.43%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNGR
201
DELISTED
Hanger Inc.
HNGR
$935K 0.16%
+51,575
New +$959K
MGLN
202
DELISTED
Magellan Health Services, Inc.
MGLN
$929K 0.16%
9,780
+1,083
+12% +$103K
BMTC
203
DELISTED
Bryn Mawr Bank Corp
BMTC
$890K 0.16%
19,765
-11,561
-37% -$544K
SHYD icon
204
VanEck Short High Yield Muni ETF
SHYD
$455M
$885K 0.16%
35,200
KMT icon
205
Kennametal
KMT
$2.3B
$882K 0.16%
24,573
-394
-2% -$14.7K
PLPC icon
206
Preformed Line Products
PLPC
$2.35B
$848K 0.15%
13,112
-5,280
-29% -$345K
CLX icon
207
Clorox
CLX
$13.1B
$835K 0.15%
4,789
-45
-0.9% -$7.5K
OPLN
208
Openlane
OPLN
$4.48B
$783K 0.14%
50,134
-11,358
-18% -$174K
LKQ icon
209
LKQ Corp
LKQ
$6.25B
$782K 0.14%
13,029
-355
-3% -$20K
SBH icon
210
Sally Beauty Holdings
SBH
$1.58B
$749K 0.13%
40,560
-15,685
-28% -$286K
ELV icon
211
Elevance Health
ELV
$84.7B
$748K 0.13%
1,613
-40
-2% -$16.8K
AVO icon
212
Mission Produce
AVO
$1.14B
$747K 0.13%
47,560
+2,423
+5% +$45.1K
TGT icon
213
Target
TGT
$69.2B
$744K 0.13%
3,216
-35
-1% -$8.51K
SUB icon
214
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$714K 0.13%
6,650
ALCO icon
215
Alico
ALCO
$307M
$694K 0.12%
18,736
-327
-2% -$11.7K
FDS icon
216
Factset
FDS
$10.1B
$650K 0.11%
1,337
-26
-2% -$11.7K
META icon
217
Meta Platforms (Facebook)
META
$1.53T
$644K 0.11%
1,916
-52
-3% -$17.3K
CHD icon
218
Church & Dwight Co
CHD
$24.4B
$609K 0.11%
5,942
-156
-3% -$14.1K
PH icon
219
Parker-Hannifin
PH
$134B
$515K 0.09%
1,618
-39
-2% -$12.1K
ALV icon
220
Autoliv
ALV
$8.96B
$504K 0.09%
4,875
-146
-3% -$14.3K
DOX icon
221
Amdocs
DOX
$6.1B
$463K 0.08%
6,192
-198
-3% -$14.9K
NEE icon
222
NextEra Energy
NEE
$179B
$429K 0.08%
4,600
UHS icon
223
Universal Health Services
UHS
$9.94B
$408K 0.07%
3,148
+847
+37% +$109K
PKG icon
224
Packaging Corp of America
PKG
$22.9B
$366K 0.06%
+2,686
New +$361K
IVE icon
225
iShares S&P 500 Value ETF
IVE
$50B
$330K 0.06%
+2,110
New +$321K

Similar funds

Dean Investment Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Dean Investment Associates held 244 positions worth $568M, up 7% from $530M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Dean Investment Associates's Q4 2021 filing shows 12 new, 60 increased, 153 reduced and 13 closed positions. Its largest new stake was Humana: 4,571 shares worth $2.12M. The largest sale was Encore Wire Corp, an estimated $3.37M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Healthcare.

  • Dean Investment Associates's largest Q4 2021 buy was Humana: 4,571 shares worth $2.12M.
  • Dean Investment Associates added most to iShares Core S&P US Value ETF in Q4 2021, an estimated $6.74M increase.
  • Dean Investment Associates's biggest Q4 2021 reduction was Encore Wire Corp, cutting an estimated $3.37M.
  • Dean Investment Associates fully exited HILL-ROM HOLDINGS, INC. in Q4 2021, selling an estimated $1.68M.
  • Dean Investment Associates's ten largest holdings make up 12% of its $568M portfolio in Q4 2021.
  • Dean Investment Associates opened 12 new positions and closed 13 in Q4 2021.
  • Dean Investment Associates's portfolio value rose 7% quarter-over-quarter to $568M.

Based on Dean Investment Associates's 13F filing for Q4 2021, filed 10 Feb 2022.